Call to Schedule Free Consultation at Over 80 Centers Worldwide!

Dr. David Greene

MD, PhD, MBA

All Posts

Avoiding Hip Replacement with Stem Cell Therapy

At the age of 63, Peggy really did not want to undergo a hip replacement. As a world record holding powerlifter, she knew that a joint replacement would prohibit her from ever competing again. Plus, she wanted to avoid the risks involved. A friend told

Read More

Get Your Nominations in for the R3 Stem Cell Heroes Program

R3 Stem Cell is now accepting nominations for its Heroes Program. We are offering ten free stem cell therapies to military vets, and they will be chosen from YOUR nominations. Submit as many as you would like by going to this page: R3StemCell.com/HERO For now,

Read More

R3 Stem Cell Now Offering a Free Cryogenic Freezer Program

The nation’s leader in regenerative therapies, R3 Stem Cell, is now offering providers a free cryogenic freezer program. The program is offered to R3’s Partners, and does not involve any up front investment. The cryogenic freezers keep the regenerative biologics at temperatures of -80 degrees

Read More

Stem cell treatment for Congestive Heart Failure

Heart failure is a serious medical condition in which the heart is unable to effectively pump blood throughout the body for its normal function. It has a wide range of structural, electrical or functional causes. Common causes include cardiomyopathy, hypertension, heart valve problems and coronary

Read More

Causes of Death in Dementia Patients

Dementia is a progressive neurological condition. It doesn’t just cause memory loss, but also damage to other parts of the brain, which are responsible for controlling our vital organ-systems This is why, eventually, it causes death. Common causes of dementia include Alzheimer’s disease, Lewy body

Read More

Stem Cell Therapy for Alzheimers

Stem Cell Therapy for Alzheimer’s Disease Alzheimer’s disease (AD) is characterized by progressive loss of cognitive functioning. There are currently 36 million people afflicted by this condition worldwide, and that number is expected to triple by the year 2050. Treatment of AD poses many challenges,

Read More